These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8264554)

  • 1. Stable allosteric binding of m1-toxin to m1 muscarinic receptors.
    Max SI; Liang JS; Potter LT
    Mol Pharmacol; 1993 Dec; 44(6):1171-5. PubMed ID: 8264554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of m1-toxin as a selective antagonist of m1 muscarinic receptors.
    Max SI; Liang JS; Valentine HH; Potter LT
    J Pharmacol Exp Ther; 1993 Oct; 267(1):480-5. PubMed ID: 8229778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site-directed mutagenesis of m1-toxin1: two amino acids responsible for stable toxin binding to M(1) muscarinic receptors.
    Krajewski JL; Dickerson IM; Potter LT
    Mol Pharmacol; 2001 Oct; 60(4):725-31. PubMed ID: 11562434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subtype selectivity of the positive allosteric action of alcuronium at cloned M1-M5 muscarinic acetylcholine receptors.
    Jakubík J; Bacáková L; el-Fakahany EE; Tucek S
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1077-83. PubMed ID: 7562472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
    Burke RE
    Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of ligand choice on the apparent binding profile of gallamine to cardiac muscarinic receptors. Identification of three main types of gallamine-muscarinic receptor interactions.
    Lee NH; el-Fakahany EE
    J Pharmacol Exp Ther; 1988 Sep; 246(3):829-38. PubMed ID: 3418516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of neuromuscular blocking drugs with recombinant human m1-m5 muscarinic receptors expressed in Chinese hamster ovary cells.
    Cembala TM; Sherwin JD; Tidmarsh MD; Appadu BL; Lambert DG
    Br J Pharmacol; 1998 Nov; 125(5):1088-94. PubMed ID: 9846649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recognition of muscarinic cholinergic receptors in human SK-N-SH neuroblastoma cells by quaternary and tertiary ligands is dependent upon temperature, cell integrity, and the presence of agonists.
    Fisher SK
    Mol Pharmacol; 1988 Apr; 33(4):414-22. PubMed ID: 3357485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of various allosteric interaction sites on M1 muscarinic receptor using 125I-Met35-oxidized muscarinic toxin 7.
    Fruchart-Gaillard C; Mourier G; Marquer C; Ménez A; Servent D
    Mol Pharmacol; 2006 May; 69(5):1641-51. PubMed ID: 16439611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of acetylcholine muscarinic M(1) receptor function by the M(1)-selective ligand muscarinic toxin 7 (MT-7).
    Olianas MC; Maullu C; Adem A; Mulugeta E; Karlsson E; Onali P
    Br J Pharmacol; 2000 Oct; 131(3):447-52. PubMed ID: 11015294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and properties of m1-toxin, a specific antagonist of m1 muscarinic receptors.
    Max SI; Liang JS; Potter LT
    J Neurosci; 1993 Oct; 13(10):4293-300. PubMed ID: 8410188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetrahydroaminoacridine and other allosteric antagonists of hippocampal M1 muscarine receptors.
    Potter LT; Ferrendelli CA; Hanchett HE; Hollifield MA; Lorenzi MV
    Mol Pharmacol; 1989 May; 35(5):652-60. PubMed ID: 2725474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stabilization of antagonist binding to cardiac muscarinic acetylcholine receptors by gallamine and other neuromuscular blocking drugs.
    Nedoma J; Tucek S; Danilov AF; Shelkovnikov SA
    J Pharmacol Exp Ther; 1986 Jan; 236(1):219-23. PubMed ID: 3941394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacological action of MT-7.
    Onali P; Adem A; Karlsson E; Olianas MC
    Life Sci; 2005 Feb; 76(14):1547-52. PubMed ID: 15680165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of orthosteric and allosteric ligands with [3H]dimethyl-W84 at the common allosteric site of muscarinic M2 receptors.
    Tränkle C; Weyand O; Voigtländer U; Mynett A; Lazareno S; Birdsall NJ; Mohr K
    Mol Pharmacol; 2003 Jul; 64(1):180-90. PubMed ID: 12815174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The quaternary transformation products of N-(3-chloropropyl)-4-piperidinyl diphenylacetate and N-(2-chloroethyl)-4-piperidinyl diphenylacetate (4-DAMP mustard) have differential affinity for subtypes of the muscarinic receptor.
    Ehlert FJ; Oliff HS; Griffin MT
    J Pharmacol Exp Ther; 1996 Feb; 276(2):405-10. PubMed ID: 8632303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the allosteric interactions of the bisquaternary heptane-1,7-bis(dimethyl-3'-phthalimidopropyl)ammonium bromide at M1 and M2 muscarine receptors.
    Christopoulos A; Mitchelson F
    Mol Pharmacol; 1994 Jul; 46(1):105-14. PubMed ID: 8058045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel multivalent ligand that bridges the allosteric and orthosteric binding sites of the M2 muscarinic receptor.
    Steinfeld T; Mammen M; Smith JA; Wilson RD; Jasper JR
    Mol Pharmacol; 2007 Aug; 72(2):291-302. PubMed ID: 17478612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. m1-toxin.
    Potter LT; Hanchett-Valentine H; Liang JS; Max SI; Purkerson SL; Silberberg HA; Strauss WL
    Life Sci; 1993; 52(5-6):433-40. PubMed ID: 8441325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allosteric regulation of cloned m1-m5 muscarinic receptor subtypes.
    Ellis J; Huyler J; Brann MR
    Biochem Pharmacol; 1991 Oct; 42(10):1927-32. PubMed ID: 1741770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.